<!DOCTYPE html>
<html>
    <head>
        <title>XORTX Therapeutics Inc. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)</title>
        <link href="https://ir.stockpr.com/xortx/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
        <script type="text/javascript" src="https://ir.stockpr.com/javascripts/ir.js"></script>
        <link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
        <script type="text/javascript" src="https://d1io3yog0oux5.cloudfront.net/_b3475d553e785ae28cebc225ec04d803/xortx/files/theme/js/aside/ir/_js/all.js"></script>
    </head>
    <body>
        <div class="xbrl-content">
            <h3>Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)</h3>
            <div id="xbrl-menu-top">
                <div class="navigation">
                    <ul class="xbrl-sf-menu">
                        
                            <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/65">Cover</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/65">Cover</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/66">Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/66">Consolidated Statements of Financial Position</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/67">Consolidated Statements of Comprehensive Loss</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/68">Consolidated Statements of Changes in Shareholders&#039; Equity</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/69">Consolidated Statements of Cash Flows</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/70">Notes to Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/70">Nature of operations</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/71">Basis of preparation</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/72">Accounting policies</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/73">Critical accounting judgments and estimates</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/74">Cash and cash equivalents</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/75">Prepaid expenses</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/76">Contract payments</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/77">Intangible assets</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/78">Right-of-use asset</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/79">Equipment</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/80">Accounts payable and accrued liabilities</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/81">Lease obligation</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/82">Share capital and reserves</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/83">Related party transactions</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/84">Income taxes</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/85">Financial instruments and risk management</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/86">Capital management</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/87">Commitments</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/88">Segmented information</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/89">Accounting Policies</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/89">Accounting policies (Policies)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/90">Notes Tables</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/90">Basis of preparation (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/91">Accounting policies (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/92">Prepaid expenses (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/93">Intangible assets (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/94">Right-of-use asset (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/95">Equipment (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/96">Accounts payable and accrued liabilities (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/97">Lease obligation (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/98">Share capital and reserves (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/99">Related party transactions (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/100">Income taxes (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/101">Financial instruments and risk management (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/102">Commitments (Tables)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item current" href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/103">Notes Details</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/103">Basis of preparation (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/104">Accounting policies (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/105">Cash and cash equivalents (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/106">Summary of prepaid expenses (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/107">Contract payment (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/108">Intangible assets (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/109">Intangible assets - other details (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/110">Right-of-use asset (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/111">Equipment (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/112">Accounts payable and accrued liabilities (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/113">Lease obligation - Reconciliation of obligation (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/114">Lease obligation - Future payments (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/115">Share capital and reserves- Authorized and issued (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/116">Share capital and reserves - Issuances (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/117">Share capital and reserves - Issuances (Additional information) (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/118">Share capital and reserves - IPO Offering (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/119">A summary of the changes in warrants for the years ended December 31, 2021 and 2020 is presented below: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/120">The following table summarizes information on warrants outstanding at December 31, 2021: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/121">A summary of the changes in finders&#039; warrants for the years ended December 31, 2021 and 2020 is presented below: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/122">The following table summarizes information on finders&#039; warrants outstanding at December 31, 2021: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/123">The fair value of stock options granted was estimated on the date of grant using the Black-Scholes model with the following data and assumptions: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/124">A summary of the changes in stock options for the years ended December 31, 2021 and 2020 is presented below: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/125">The following table summarizes information on stock options outstanding at December 31, 2021: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/126">The balance of the derivative warrant liabilities (level 3) is as follows: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/127">Significant assumptions used in determining the fair value of the derivative warrant liabilities at December 31, 2021 are as follows: (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/128">Share capital and reserves (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/129">Related party transactions (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/130">Related party transactions - Management compensation transactions (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/131">Income taxes (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/132">Income taxes - Significant components of the Company&#039;s deferred tax assets (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/133">Income taxes - Schedule of losses expire (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/134">Financial instruments and risk management (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/135">Financial instruments and risk management - Company&#039;s risk exposures and their impact on the financial instruments (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/136">Financial instruments and risk management - Contractual maturities of these financial liabilities (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/137">Financial instruments and risk management - Foreign Currency Risk (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/138">Commitments (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/139">Commitments - Employment Agreements (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/140">Commitments - Additional Information (Details)</a></li>
                                                                    </ul>
                            </li>
                                            </ul>
                </div>
            </div>
            <div class="spr-xbrl-document">
                <h4>Related party transactions - Management compensation transactions (Details)</h4>
                                <div style="clear:both;"></div>
            </div>
        </div>
    </body>
</html>